In vivo delineation of myocardial hypoxia during coronary occlusion using fluorine-18 fluoromisonidazole and positron emission tomography: A potential approach for identification of jeopardized myocardium
- 1 August 1990
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 16 (2) , 477-485
- https://doi.org/10.1016/0735-1097(90)90606-p
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Substrate use in ischemic and reperfused canine myocardium: quantitative considerationsAmerican Journal of Physiology-Heart and Circulatory Physiology, 1987
- Rubidium-82 Myocardial Uptake and Extraction After Transient IschemiaJournal of Computer Assisted Tomography, 1987
- Regional myocardial metabolism in patients with acute myocardial infarction assessed by positron emission tomographyJournal of the American College of Cardiology, 1986
- Reversibility of Cardiac Wall-Motion Abnormalities Predicted by Positron TomographyNew England Journal of Medicine, 1986
- Kinetics of rubidium-82 after coronary occlusion and reperfusion. Assessment of patency and viability in open-chested dogs.Journal of Clinical Investigation, 1985
- Metabolism induced binding of 4C-misonidazole to hypoxic cells: Kinetic dependence on oxygen concentration and misonidazole concentrationInternational Journal of Radiation Oncology*Biology*Physics, 1984
- Intracellular localization of radioactively labeled misonidazole in EMT-6 tumor cells in vitroInternational Journal of Radiation Oncology*Biology*Physics, 1982
- Binding of misonidazole to EMT6 AND V79 spheroidsInternational Journal of Radiation Oncology*Biology*Physics, 1982
- Hypoxic Sensitizers — Implications for Radiation TherapyNew England Journal of Medicine, 1979
- Reduced reflow and diminished uptake of 86Rb after temporary coronary occlusionAmerican Journal of Physiology-Heart and Circulatory Physiology, 1978